T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.18% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Urban Edge Properties
UE
$2.76B
| $1.68M | ﹤0.01% |
110,334
-8,930
| -7% | -$160K |
|
1677
iShares Russell 1000 Value ETF
IWD
$84.3B
| $1.68M | ﹤0.01% |
11,551
| – | – |
|
1678
UMB Financial
UMBF
$11.5B
| $1.67M | ﹤0.01% |
19,411
+243
| +1% | +$22K |
|
|
FBRT
1679
Franklin BSP Realty Trust
FBRT
$669M
| $1.65M | ﹤0.01% |
122,518
+4,853
| +4% | +$69.1K |
|
1680
Integra LifeSciences
IART
$1.42B
| $1.63M | ﹤0.01% |
30,212
+149
| +0.5% | +$8.95K |
|
1681
Arrowhead Research
ARWR
$12.3B
| $1.63M | ﹤0.01% |
46,186
-2,555
| -5% | -$96.1K |
|
1682
Trinity Industries
TRN
$2.36B
| $1.63M | ﹤0.01% |
67,090
-5,473
| -8% | -$148K |
|
1683
Goodyear
GT
$1.75B
| $1.61M | ﹤0.01% |
150,820
-5,218
| -3% | -$65.3K |
|
1684
Toll Brothers
TOL
$13.9B
| $1.61M | ﹤0.01% |
36,167
-2,639
| -7% | -$123K |
|
1685
Dycom Industries
DY
$12.5B
| $1.61M | ﹤0.01% |
17,268
+148
| +0.9% | +$13.2K |
|
|
CSGS
1686
DELISTED
CSG Systems International
CSGS
| $1.6M | ﹤0.01% |
26,892
+699
| +3% | +$42.3K |
|
1687
Prelude Therapeutics
PRLD
$425M
| $1.6M | ﹤0.01% |
307,353
-15,635
| -5% | -$79.6K |
|
1688
Enpro
NPO
$7.24B
| $1.6M | ﹤0.01% |
19,552
+171
| +0.9% | +$15.9K |
|
1689
Viavi Solutions
VIAV
$10.5B
| $1.6M | ﹤0.01% |
120,806
+2,147
| +2% | +$30.9K |
|
1690
Carlyle Group
CG
$17.6B
| $1.59M | ﹤0.01% |
50,119
+1,517
| +3% | +$58.1K |
|
1691
Kite Realty
KRG
$5.29B
| $1.59M | ﹤0.01% |
91,772
+1,376
| +2% | +$28.4K |
|
1692
Interactive Brokers
IBKR
$41.7B
| $1.58M | ﹤0.01% |
115,056
-1,504
| -1% | -$22.3K |
|
1693
SITE Centers
SITC
$156M
| $1.58M | ﹤0.01% |
150,547
+3,980
| +3% | +$47K |
|
1694
United Natural Foods
UNFI
$2.91B
| $1.58M | ﹤0.01% |
40,139
-5,227
| -12% | -$220K |
|
|
JHG
1695
DELISTED
Janus Henderson
JHG
| $1.58M | ﹤0.01% |
67,225
-696
| -1% | -$20K |
|
1696
Tenaris
TS
$27.1B
| $1.58M | ﹤0.01% |
61,500
-87,400
| -59% | -$2.69M |
|
|
COWN
1697
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.57M | ﹤0.01% |
66,368
+2,700
| +4% | +$65.5K |
|
1698
BARK
BARK
$94.1M
| $1.57M | ﹤0.01% |
+61,211
| New | +$3.09M |
|
1699
Fox Factory Holding Corp
FOXF
$887M
| $1.56M | ﹤0.01% |
19,352
+601
| +3% | +$50.6K |
|
1700
Ashland
ASH
$3.35B
| $1.56M | ﹤0.01% |
15,099
+70
| +0.5% | +$7.16K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.